Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1334
mi
from 91732
Saint Joseph, MO
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1334
mi
from 91732
Saint Joseph, MO
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1301
mi
from 91732
Omaha, NE
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1301
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
217
mi
from 91732
Las Vegas, NV
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
217
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2351
mi
from 91732
New York, NY
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2351
mi
from 91732
New York, NY
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2245
mi
from 91732
Rochester, NY
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2245
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigator Site
828
mi
from 91732
Portland, OR
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigator Site
828
mi
from 91732
Portland, OR
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2019
mi
from 91732
Greenville, SC
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2019
mi
from 91732
Greenville, SC
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1923
mi
from 91732
Knoxville, TN
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1923
mi
from 91732
Knoxville, TN
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1358
mi
from 91732
Houston, TX
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1358
mi
from 91732
Houston, TX
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2176
mi
from 91732
Lynchburg, VA
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2176
mi
from 91732
Lynchburg, VA
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2337
mi
from 91732
Norfolk, VA
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2337
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
A Bioavailability Study of DFD-03 (Tazarotene, Lotion 0.1 % ) Compared to Tazorac® (Tazarotene), 0.1% in Patients With Moderate Acne Vulgaris
A Randomized, Open-Label, Multiple Dose, Bioavailability Study of DFD-03 (Tazarotene Lotion, 0.1 % ) Dosed Twice Daily Compared to Once Daily Tazorac® (Tazarotene) Cream, 0.1% in Patients With Moderate Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Dr. DuBois
mi
from 91732
Austin, TX
A Bioavailability Study of DFD-03 (Tazarotene, Lotion 0.1 % ) Compared to Tazorac® (Tazarotene), 0.1% in Patients With Moderate Acne Vulgaris
A Randomized, Open-Label, Multiple Dose, Bioavailability Study of DFD-03 (Tazarotene Lotion, 0.1 % ) Dosed Twice Daily Compared to Once Daily Tazorac® (Tazarotene) Cream, 0.1% in Patients With Moderate Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Dr. DuBois
mi
from 91732
Austin, TX
Click here to add this to my saved trials
A Bioavailability Study of DFD-03 (Tazarotene, Lotion 0.1 % ) Compared to Tazorac® (Tazarotene), 0.1% in Patients With Moderate Acne Vulgaris
A Randomized, Open-Label, Multiple Dose, Bioavailability Study of DFD-03 (Tazarotene Lotion, 0.1 % ) Dosed Twice Daily Compared to Once Daily Tazorac® (Tazarotene) Cream, 0.1% in Patients With Moderate Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Dr. Jones
mi
from 91732
Austin, TX
A Bioavailability Study of DFD-03 (Tazarotene, Lotion 0.1 % ) Compared to Tazorac® (Tazarotene), 0.1% in Patients With Moderate Acne Vulgaris
A Randomized, Open-Label, Multiple Dose, Bioavailability Study of DFD-03 (Tazarotene Lotion, 0.1 % ) Dosed Twice Daily Compared to Once Daily Tazorac® (Tazarotene) Cream, 0.1% in Patients With Moderate Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Dr. Jones
mi
from 91732
Austin, TX
Click here to add this to my saved trials
Evaluation of the Ulthera® System and Efficacy Correlation to Morphological Differences
Evaluation of the Ulthera® System and Efficacy Correlation to Morphological Differences
Status: Enrolling
Updated:  12/31/1969
Clinical Testing of Beverly Hills
22
mi
from 91732
Beverly Hills, CA
Evaluation of the Ulthera® System and Efficacy Correlation to Morphological Differences
Evaluation of the Ulthera® System and Efficacy Correlation to Morphological Differences
Status: Enrolling
Updated: 12/31/1969
Clinical Testing of Beverly Hills
22
mi
from 91732
Beverly Hills, CA
Click here to add this to my saved trials
UV Exposure Assessed With Wearable Sensor and Sun Protection
A Real-time, Cost-effective, Accurate UV Measurement and Sun Protection System to Prevent and Reduce the Incidence of Sunburn in High-risk Consumers
Status: Enrolling
Updated:  12/31/1969
Northwestern University, Feinberg School of Medicine, Department of Dermatology
1730
mi
from 91732
Chicago, IL
UV Exposure Assessed With Wearable Sensor and Sun Protection
A Real-time, Cost-effective, Accurate UV Measurement and Sun Protection System to Prevent and Reduce the Incidence of Sunburn in High-risk Consumers
Status: Enrolling
Updated: 12/31/1969
Northwestern University, Feinberg School of Medicine, Department of Dermatology
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
Status: Enrolling
Updated:  12/31/1969
University of Chicago
1730
mi
from 91732
Chicago, IL
Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
Status: Enrolling
Updated: 12/31/1969
University of Chicago
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
Phase 1, Randomized, Double-Blind, Vehicle-Controlled Study of Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Subjects With Female Pattern Hair Loss
Status: Enrolling
Updated:  12/31/1969
Cosmetic Laser Dermatology
93
mi
from 91732
San Diego, CA
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
Phase 1, Randomized, Double-Blind, Vehicle-Controlled Study of Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Subjects With Female Pattern Hair Loss
Status: Enrolling
Updated: 12/31/1969
Cosmetic Laser Dermatology
93
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis
Phase IIB Randomized, Double-Blinded, Placebo Controlled Study to Evaluate the Safety and Efficacy of Topical Difluoromethylornithine (DFMO) With and Without a Topical Corticosteroid Cream (Triamcinolone 0.1%) in the Therapy of Actinic Keratoses (AK) on the Forearms
Status: Enrolling
Updated:  12/31/1969
Arizona Cancer Center
426
mi
from 91732
Tucson, AZ
Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis
Phase IIB Randomized, Double-Blinded, Placebo Controlled Study to Evaluate the Safety and Efficacy of Topical Difluoromethylornithine (DFMO) With and Without a Topical Corticosteroid Cream (Triamcinolone 0.1%) in the Therapy of Actinic Keratoses (AK) on the Forearms
Status: Enrolling
Updated: 12/31/1969
Arizona Cancer Center
426
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis
An Investigator Blinded, Randomized, Controlled Study Comparing the Efficacy and Cost-Effectiveness of Aquaphor Healing Ointment, Atopiclair Nonsteroidal Cream (MAS063DP) and EpiCeram Skin Barrier Emulsion in Children With Mild to Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Medical Center
2126
mi
from 91732
Winston-Salem, NC
Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis
An Investigator Blinded, Randomized, Controlled Study Comparing the Efficacy and Cost-Effectiveness of Aquaphor Healing Ointment, Atopiclair Nonsteroidal Cream (MAS063DP) and EpiCeram Skin Barrier Emulsion in Children With Mild to Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Medical Center
2126
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne
Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide 2.5% in Moderate to Severe Acne in Dark Skin Phototype Subjects
Status: Enrolling
Updated:  12/31/1969
DermResearch, Inc.
1208
mi
from 91732
Austin, TX
Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne
Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide 2.5% in Moderate to Severe Acne in Dark Skin Phototype Subjects
Status: Enrolling
Updated: 12/31/1969
DermResearch, Inc.
1208
mi
from 91732
Austin, TX
Click here to add this to my saved trials
Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne
Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide 2.5% in Moderate to Severe Acne in Dark Skin Phototype Subjects
Status: Enrolling
Updated:  12/31/1969
CIDP
mi
from 91732
Phoenix,
Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne
Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide 2.5% in Moderate to Severe Acne in Dark Skin Phototype Subjects
Status: Enrolling
Updated: 12/31/1969
CIDP
mi
from 91732
Phoenix,
Click here to add this to my saved trials
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Unison Center for Clinical Trials
mi
from 91732
Sherman Oaks, CA
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Unison Center for Clinical Trials
mi
from 91732
Sherman Oaks, CA
Click here to add this to my saved trials
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Moore Clinical Research Institute, Inc.
mi
from 91732
Brandon, FL
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Moore Clinical Research Institute, Inc.
mi
from 91732
Brandon, FL
Click here to add this to my saved trials
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
FXM Research Corp.
2310
mi
from 91732
Miami, FL
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
FXM Research Corp.
2310
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
FXM Research Miramar
2307
mi
from 91732
Miramar, FL
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
FXM Research Miramar
2307
mi
from 91732
Miramar, FL
Click here to add this to my saved trials
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Moore Clinical Research Institute, Inc.
mi
from 91732
Tampa, FL
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Moore Clinical Research Institute, Inc.
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
Dermatology Consulting Services
2140
mi
from 91732
High Point, NC
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
Dermatology Consulting Services
2140
mi
from 91732
High Point, NC
Click here to add this to my saved trials
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
3A Research, LLC
mi
from 91732
El Paso, TX
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
3A Research, LLC
mi
from 91732
El Paso, TX
Click here to add this to my saved trials
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated:  12/31/1969
FXM Research International
mi
from 91732
Belize City,
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
Status: Enrolling
Updated: 12/31/1969
FXM Research International
mi
from 91732
Belize City,
Click here to add this to my saved trials
Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis
A Phase 2, Single-Center, Randomized, Double- Blind, Parallel-Group, Vehicle-Controlled Study Evaluating the Efficacy and Safety of AM001 Cream in the Treatment of Actinic Keratosis (AK) Lesions
Status: Enrolling
Updated:  12/31/1969
AmDerma Pharmaceuticals, LLC
mi
from 91732
High Point, NC
Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis
A Phase 2, Single-Center, Randomized, Double- Blind, Parallel-Group, Vehicle-Controlled Study Evaluating the Efficacy and Safety of AM001 Cream in the Treatment of Actinic Keratosis (AK) Lesions
Status: Enrolling
Updated: 12/31/1969
AmDerma Pharmaceuticals, LLC
mi
from 91732
High Point, NC
Click here to add this to my saved trials
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
Status: Enrolling
Updated:  12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from 91732
New York, NY
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from 91732
New York, NY
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
336
mi
from 91732
Glendale, AZ
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
336
mi
from 91732
Glendale, AZ
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1340
mi
from 91732
Fort Smith, AR
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1340
mi
from 91732
Fort Smith, AR
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
82
mi
from 91732
Encinitas, CA
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
82
mi
from 91732
Encinitas, CA
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
106
mi
from 91732
San Diego, CA
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
106
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
818
mi
from 91732
Denver, CO
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
818
mi
from 91732
Denver, CO
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from 91732
Coral Gables, FL
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from 91732
Coral Gables, FL
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2322
mi
from 91732
Miami, FL
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2322
mi
from 91732
Miami, FL
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1809
mi
from 91732
New Albany, IN
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1809
mi
from 91732
New Albany, IN
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2274
mi
from 91732
Rockville, MD
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2274
mi
from 91732
Rockville, MD
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from 91732
Quincy, MA
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from 91732
Quincy, MA
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1334
mi
from 91732
Saint Joseph, MO
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1334
mi
from 91732
Saint Joseph, MO
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1301
mi
from 91732
Omaha, NE
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1301
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2245
mi
from 91732
Rochester, NY
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2245
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2218
mi
from 91732
Raleigh, NC
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2218
mi
from 91732
Raleigh, NC
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
mi
from 91732
Beachwood, OH
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from 91732
Beachwood, OH
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2114
mi
from 91732
Upper Saint Clair, PA
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2114
mi
from 91732
Upper Saint Clair, PA
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2008
mi
from 91732
Anderson, SC
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2008
mi
from 91732
Anderson, SC
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1923
mi
from 91732
Knoxville, TN
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1923
mi
from 91732
Knoxville, TN
Click here to add this to my saved trials
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1763
mi
from 91732
Nashville, TN
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials